TNF and infection: [85] While the overall quality of evidence in these summarized studies was limited, Bouhuys et al. still described how an anti-TNF-α de-escalation did not reduce the occurrence of infections and skin manifestations compared to patients who continued standard dosing according to the label’s recommendation [85].